In the current environment of moderating interest rates and resilient corporate balance sheets, merger and acquisition activity has shown signs of recovery as companies pursue growth through strategic deals. With the Federal Reserve's policy path influencing borrowing costs, lower Treasury yields have eased financing conditions for leveraged buyouts and cash acquisitions. Key sectors including technology and healthcare continue to attract interest due to innovation pipelines and scale opportunities, while antitrust scrutiny remains a variable in large transactions. Traders are monitoring upcoming economic releases such as GDP and inflation data for signals on sustained deal momentum through the end of 2026, alongside any shifts in regulatory stances from competition authorities.